Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study
Authors
Keywords
-
Journal
FERTILITY AND STERILITY
Volume 118, Issue 2, Pages 371-381
Publisher
Elsevier BV
Online
2022-06-13
DOI
10.1016/j.fertnstert.2022.04.027
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Incretin Hormones in Obesity and Related Cardiometabolic Disorders: The Clinical Perspective
- (2021) Joanna Michałowska et al. Nutrients
- Postpartum treatment with liraglutide in combination with metformin versus metformin monotherapy to improve metabolic status and reduce body weight in overweight/obese women with recent gestational diabetes: A double-blind, randomized, placebo-controlled study
- (2020) Karen E. Elkind-Hirsch et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Liraglutide: New Perspectives for the Treatment of Polycystic Ovary Syndrome
- (2020) Georgios S. Papaetis et al. CLINICAL DRUG INVESTIGATION
- 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021
- (2020) DIABETES CARE
- Effects of liraglutide on ovarian dysfunction in polycystic ovary syndrome: a randomized clinical trial
- (2017) Malin Nylander et al. REPRODUCTIVE BIOMEDICINE ONLINE
- Short-term effectiveness of low dose liraglutide in combination with metformin versus high dose liraglutide alone in treatment of obese PCOS: randomized trial
- (2017) Mojca Jensterle et al. BMC Endocrine Disorders
- GLP-1 receptor agonists in the treatment of polycystic ovary syndrome
- (2017) Elizabeth Mary Lamos et al. Expert Review of Clinical Pharmacology
- Glucagon-like peptide 1 improves insulin resistance in vitro through anti-inflammation of macrophages
- (2016) C. Guo et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic–hyperinsulinaemic clamp studies
- (2016) Samantha Cassar et al. HUMAN REPRODUCTION
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- New therapeutic approaches for the treatment of obesity
- (2016) Alan R. Saltiel Science Translational Medicine
- Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes
- (2015) Melanie J. Davies et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
- (2015) Xavier Pi-Sunyer et al. NEW ENGLAND JOURNAL OF MEDICINE
- The role of androgens in metabolism, obesity, and diabetes in males and females
- (2015) Guadalupe Navarro et al. Obesity
- Short-term intervention with liraglutide improved eating behavior in obese women with polycystic ovary syndrome
- (2014) Mojca Jensterle et al. ENDOCRINE RESEARCH
- Índice triglicéridos y glucosa: un indicador útil de insulinorresistencia
- (2014) Gisela Unger et al. Endocrinologia y Nutricion
- Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adults
- (2013) M E J Lean et al. INTERNATIONAL JOURNAL OF OBESITY
- Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis
- (2012) S.S. Lim et al. HUMAN REPRODUCTION UPDATE
- The association between triglyceride to high-density-lipoprotein cholesterol ratio and insulin resistance in a multiethnic primary prevention cohort
- (2011) Danijela Gasevic et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1-5 studies
- (2009) L. Blonde et al. DIABETES OBESITY & METABOLISM
- The effects of glucagon-like peptide-1 on the beta cell
- (2009) T. Vilsbøll DIABETES OBESITY & METABOLISM
- The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria
- (2009) W. A. March et al. HUMAN REPRODUCTION
- Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
- (2009) Arne Astrup et al. LANCET
- Comparison of Single and Combined Treatment with Exenatide and Metformin on Menstrual Cyclicity in Overweight Women with Polycystic Ovary Syndrome
- (2008) Karen Elkind-Hirsch et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Effect of a Hypocaloric Diet with and without Exercise Training on Body Composition, Cardiometabolic Risk Profile, and Reproductive Function in Overweight and Obese Women with Polycystic Ovary Syndrome
- (2008) Rebecca L. Thomson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis
- (2008) Crystal Man Ying Lee et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Impact of Obesity on the Risk for Polycystic Ovary Syndrome
- (2007) Bulent O. Yildiz et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now